Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

July 22, 2017

Chicago, Illinois

Agenda

Saturday, July 22, 2017

Session I: Evolving Approaches to Current Clinical Challenges

8:00 am

Welcome and pre-activity learner survey

8:10 am

What factors influence choice of first therapy in IBD: How can we predict response and be smarter?

8:30 am

Understanding non-response and loss of response in IBD: Which is it and when do we change classes?

8:50 am

Therapeutic drug monitoring: Should we use it routinely or occasionally in IBD?

9:10 am

Getting your patient on therapy: What resources are available and how can we do this better?

9:30 am

Faculty discussion

10:00 am

Post-activity knowledge/competence assessment via ARS

10:10 am

Break

Session II: Emerging Therapies

10:40 am

Pre-activity knowledge/competence assessment via ARS

10:50 am

Role of emerging therapies in IBD: Where will they belong in our algorithms?

11:10 am

The emerging world of biosimilars: What do we know about interchangeability and extrapolation?

11:40 am

State of art in diet and microbiome: Are we there yet?

12:00 pm

Bench to bedside top 10: What did we learn about IBD research and upcoming therapies from DDW 2017?

12:20 pm

Faculty discussion

12:50 pm

Post-activity knowledge/competence assessment via ARS

1:00 pm

Lunch

Session III: Specific patient types

2:15 pm

Pre-activity knowledge/competence assessment via ARS

2:25 pm

Management of joint pain in IBD (rheumatology)

2:45 pm

Management of rash in IBD (dermatology)

3:05 pm

Faculty discussion

3:35 pm

Case discussion: Management of the complex pouch patient

3:55 pm

Case discussion: Management of severe IBD non-responsive to TNF-inhibitor therapy

4:15 pm

Case discussion: Management of the post-op patient with complications

4:45 pm

Final remarks, recap of key points, and post-activity knowledge/competence assessment via ARS

5:00 pm

Adjourn